,datetime,sentence,positive,negative,neutral,global_sentiment,avg_sentiment
0,2017-12-21 00:01:00,Few industries have given shareholders returns like those of the healthcare sector over the past few decades.,0.36677345633506775,0.015446553006768227,0.6177799701690674,neutral,0.35132691264152527
1,2017-12-21 00:01:00,Two companies at the forefront of that tide are Veeva Systems (NYSE: VEEV) and Cerner (NASDAQ: CERN) -- and today they'll be going head-to-head.,0.4660988450050354,0.01666116528213024,0.5172399878501892,neutral,0.44943767786026
2,2017-12-21 00:01:00,"Interestingly, I authored an article with the exact same matchup 10 months ago.",0.041303735226392746,0.010130259208381176,0.9485659599304199,neutral,0.031173475086688995
3,2017-12-21 00:01:00,"Back then, I gave the nod to Veeva.",0.2179940938949585,0.026746677234768867,0.7552592754364014,neutral,0.19124741852283478
4,2017-12-21 00:01:00,"Since then, the stocks have tied; both returned 30%, handily beating the broader market.",0.9431087374687195,0.031832605600357056,0.025058738887310028,positive,0.91127610206604
5,2017-12-21 00:01:00,So how do they stack up today?,0.0393507219851017,0.020047176629304886,0.9406020641326904,neutral,0.019303545355796814
6,2017-12-21 00:01:00,"By evaluating the companies on three different criteria, we can get a better idea of what we're paying for when we buy shares and which is the better bet today.",0.16260243952274323,0.007743700407445431,0.8296538591384888,neutral,0.15485873818397522
7,2017-12-21 00:01:00,"For truly long-term investors -- we're talking a minimum of three years -- there's nothing more important to evaluate than a company's sustainable competitive advantage, often referred to as a ""moat.""",0.24529878795146942,0.00968600157648325,0.7450152039527893,neutral,0.23561277985572815
8,2017-12-21 00:01:00,"At its core, a moat is what keeps customers coming back for more while holding the competition at bay for decades.",0.4374789595603943,0.027695894241333008,0.5348251461982727,neutral,0.4097830653190613
9,2017-12-21 00:01:00,Veeva's key moat is provided by high switching costs.,0.43514928221702576,0.010633307509124279,0.5542174577713013,neutral,0.424515962600708
10,2017-12-21 00:01:00,The company got its start providing software-as-a-service (SaaS) for customer relationship management (CRM).,0.17629466950893402,0.0055580735206604,0.8181473016738892,neutral,0.17073659598827362
11,2017-12-21 00:01:00,"But the real coup has come from Veeva Vault, which has several subcategories that help drug companies do everything from capture electronic data from clinical trials to managing regulatory requirements.",0.10727205872535706,0.006624392233788967,0.8861035704612732,neutral,0.10064766556024551
12,2017-12-21 00:01:00,As more and more companies sign on -- and use more and more Vault applications -- switching costs for those clients soar.,0.15163195133209229,0.5100268721580505,0.33834120631217957,negative,-0.35839492082595825
13,2017-12-21 00:01:00,"Last quarter, management reported that the number of clients using multiple Vault applications grew 50%, an enormously positive sign for the company's shareholders.",0.9525116086006165,0.01745416224002838,0.030034217983484268,positive,0.9350574612617493
14,2017-12-21 00:01:00,"Over the next year, keep an eye on two new Vault applications -- Clinical Trial Management Systems (CTMS) and Electronic Data Capture (EDC).",0.19302663207054138,0.006252313498407602,0.8007209897041321,neutral,0.18677431344985962
15,2017-12-21 00:01:00,"The former is an area of need for drug companies that are still relying on clunky legacy systems, and Veeva already has 11 companies signed on.",0.33722585439682007,0.024592434987425804,0.6381816864013672,neutral,0.3126334249973297
16,2017-12-21 00:01:00,"The latter is a more developed market, largely dominated by Oracle and Medidata Solutions.",0.08443118631839752,0.006886399816721678,0.9086824059486389,neutral,0.07754478603601456
17,2017-12-21 00:01:00,"The idea is that as drug companies start to use Veeva Vault for all of their other needs, the decision to use the company for EDC will make more sense.",0.3727603256702423,0.008301608264446259,0.6189380288124084,neutral,0.36445870995521545
18,2017-12-21 00:01:00,"Additionally, the popularity of Vault has been so high that companies outside of pharmaceuticals have been asking for access to the cloud application.",0.46807563304901123,0.014799783006310463,0.517124593257904,neutral,0.4532758593559265
19,2017-12-21 00:01:00,"These companies are largely concentrated in highly regulated industries like chemicals, manufacturing, and consumer packaged goods.",0.015786930918693542,0.006445867009460926,0.9777672290802002,neutral,0.009341063909232616
20,2017-12-21 00:01:00,"In response, management released Vault QualityOne, a solution for such companies.",0.42190980911254883,0.0180988647043705,0.5599913597106934,neutral,0.40381094813346863
21,2017-12-21 00:01:00,"Thus far, details from the effort have been scant, with management saying that it wants to focus on success with early adopters now and focus on adding more customers in 2018.",0.18552875518798828,0.028869885951280594,0.7856013774871826,neutral,0.15665887296199799
22,2017-12-21 00:01:00,"Finally, Veeva also announced an application set to become available in 2019: Vault Safety.",0.18141843378543854,0.0062857321463525295,0.8122957944869995,neutral,0.17513270676136017
23,2017-12-21 00:01:00,"This application will allow drug companies to collect data from adverse reactions to medication, handle communication with authorities, and -- most interesting to me -- attempt to use data to signal when more health problems might be on the horizon.",0.13354675471782684,0.005626908969134092,0.860826313495636,neutral,0.12791985273361206
24,2017-12-21 00:01:00,Cerner also uses the SaaS model and enjoys the benefit of high switching costs.,0.4350702464580536,0.008606628514826298,0.5563231110572815,neutral,0.42646360397338867
25,2017-12-21 00:01:00,"The company provides real-time data for doctors and other healthcare professionals and has been around for much longer than Veeva, which only got its start in 2007.",0.0571257546544075,0.008258688263595104,0.9346155524253845,neutral,0.04886706545948982
26,2017-12-21 00:01:00,"Normally, I would call this a tie, as both have enviable moats.",0.5050744414329529,0.020880116149783134,0.47404536604881287,positive,0.4841943383216858
27,2017-12-21 00:01:00,But they seem to be headed in opposite directions.,0.10274167358875275,0.15803050994873047,0.739227831363678,neutral,-0.05528883635997772
28,2017-12-21 00:01:00,"While Veeva has not only added far more customers than expected over the past three years and branched into providing software for companies in other industries, Cerner's bookings have disappointed lately.",0.026812665164470673,0.9593819975852966,0.0138052674010396,negative,-0.9325693249702454
29,2017-12-21 00:01:00,And Cerner is certainly not growing its business as quickly as Veeva is right now.,0.18001648783683777,0.13491836190223694,0.6850651502609253,neutral,0.04509812593460083
30,2017-12-21 00:01:00,"Next year's revenue is expected to be in the ballpark of 9%, while Veeva has said that it expects growth of 20% or more every quarter until 2020.",0.7738394141197205,0.012534501031041145,0.21362604200839996,positive,0.7613049149513245
31,2017-12-21 00:01:00,"Because both of these companies have high switching costs, that means lots more sticky revenue for Veeva.",0.5143015384674072,0.031023206189274788,0.45467525720596313,positive,0.4832783341407776
32,2017-12-21 00:01:00,"Ask most investors and they'll tell you that excess cash should be handled in one of two ways: given back to shareholders via buybacks or dividends, or reinvested in growth opportunities.",0.05194421485066414,0.0062248134054243565,0.9418309926986694,neutral,0.04571940004825592
33,2017-12-21 00:01:00,"While there's certainly a place for both of those, there's also something to be said for keeping a boring old pile of cash around.",0.09384848922491074,0.041077252477407455,0.8650742769241333,neutral,0.05277123674750328
34,2017-12-21 00:01:00,"That's because every company, at one point or another, is bound to run into difficult financial times.",0.04334323853254318,0.5223336219787598,0.43432313203811646,negative,-0.478990375995636
35,2017-12-21 00:01:00,"Those that have cash on hand can actually emerge from these episodes stronger by buying back shares on the cheap, acquiring distressed rivals, or outspending the competition to gain long-term market share.",0.8033396005630493,0.017713990062475204,0.17894642055034637,positive,0.7856256365776062
36,2017-12-21 00:01:00,"Keeping in mind that Cerner is valued at almost three times the size of Veeva, here's how they stack up.",0.04170777276158333,0.007882525213062763,0.9504097104072571,neutral,0.03382524847984314
37,2017-12-21 00:01:00,"Even after factoring in size, Cerner has more cash flow and net income than Veeva.",0.5924974083900452,0.02445763163268566,0.383044958114624,positive,0.5680397748947144
38,2017-12-21 00:01:00,"At the same time, Veeva's net cash position outstrips Cerner by a fairly wide margin.",0.874507486820221,0.05285485088825226,0.072637639939785,positive,0.8216526508331299
39,2017-12-21 00:01:00,But there are a few key aspects to keep in mind: Cerner is a more mature business and many of its applications are at a scale that they can enjoy robust margins.,0.7701646089553833,0.011244457215070724,0.21859094500541687,positive,0.7589201331138611
40,2017-12-21 00:01:00,"Veeva, on the other hand, has spent the money to roll out new applications (like EDC and CTMS), but has yet to achieve scale with customers.",0.8866602182388306,0.01387070957571268,0.0994691550731659,positive,0.8727895021438599
41,2017-12-21 00:01:00,"Furthermore, while some would argue that it makes sense to take on debt as Cerner has in a low-interest rate environment, Veeva's net cash position -- 70% larger than Cerner's -- gives it more flexibility if an economic crisis hit.",0.845316469669342,0.016882680356502533,0.1378009170293808,positive,0.8284338116645813
42,2017-12-21 00:01:00,"It would be easier for Veeva to buy back a larger share of stock, acquire rivals, or temporarily lower prices -- driving start-up competition into bankruptcy -- to gain and maintain market share.",0.9124466180801392,0.017774216830730438,0.06977920234203339,positive,0.8946723937988281
43,2017-12-21 00:01:00,Withstand and benefit from recessions.,0.1488051414489746,0.006881642621010542,0.8443132042884827,neutral,0.14192350208759308
44,2017-12-21 00:01:00,That's why Veeva wins this one as well.,0.2365855723619461,0.017218265682458878,0.7461961507797241,neutral,0.21936731040477753
45,2017-12-21 00:01:00,"Finally, we have valuation.",0.22249005734920502,0.010374725796282291,0.7671352028846741,neutral,0.2121153324842453
46,2017-12-21 00:01:00,There's no one metric that lets you know if a stock is cheap or expensive.,0.03113533928990364,0.011561853811144829,0.9573028087615967,neutral,0.019573485478758812
47,2017-12-21 00:01:00,"Instead, I like to look at a number of different metrics to get a more comprehensive perspective.",0.0605955645442009,0.005516471806913614,0.9338880181312561,neutral,0.05507909134030342
48,2017-12-21 00:01:00,Here are three of my favorites.,0.06915116310119629,0.0101360734552145,0.9207128286361694,neutral,0.05901508778333664
49,2017-12-21 00:01:00,"Without a doubt, Cerner is the cheaper company at today's prices.",0.4620085060596466,0.020387038588523865,0.5176044702529907,neutral,0.44162148237228394
50,2017-12-21 00:01:00,"While both companies have enviable moats, Veeva's appears to be growing, while Cerner's is either caught in neutral or shrinking.",0.7260891199111938,0.020422546193003654,0.2534883916378021,positive,0.7056666016578674
51,2017-12-21 00:01:00,"Combined with Veeva's lack of debt, I'm giving it the upper-hand, even over the demonstrably cheaper Cerner.",0.7753471732139587,0.01689549908041954,0.2077573835849762,positive,0.7584517002105713
52,2017-12-21 00:01:00,"10 stocks we like better than Veeva Systems

When investing geniuses David and Tom Gardner have a stock tip, it can pay to listen.",0.12699975073337555,0.025114860385656357,0.8478853702545166,neutral,0.1018848866224289
53,2017-12-21 00:01:00,"After all, the newsletter they have run for over a decade, Motley Fool Stock Advisor , has tripled the market.",0.46925464272499084,0.07301506400108337,0.4577302634716034,positive,0.39623957872390747
54,2017-12-21 00:01:00,"*

David and Tom just revealed what they believe are the 10 best stocks for investors to buy right now... and Veeva Systems wasn't one of them!",0.2355690747499466,0.014962825924158096,0.7494681477546692,neutral,0.2206062525510788
55,2017-12-21 00:01:00,That's right -- they think these 10 stocks are even better buys.,0.8146857619285583,0.02307075634598732,0.16224350035190582,positive,0.7916150093078613
56,2017-12-21 00:01:00,Click here to learn about these picks!,0.0694708302617073,0.055800698697566986,0.8747285008430481,neutral,0.01367013156414032
57,2017-12-21 00:01:00,Brian Stoffel owns shares of Veeva Systems.,0.016026807948946953,0.010143947787582874,0.9738292694091797,neutral,0.0058828601613640785
58,2017-12-21 00:01:00,The Motley Fool owns shares of and recommends Veeva Systems.,0.034477271139621735,0.013045232743024826,0.9524774551391602,neutral,0.02143203839659691
59,2017-12-21 00:01:00,The Motley Fool owns shares of Oracle.,0.03999162092804909,0.028421049937605858,0.9315873980522156,neutral,0.01157057099044323
60,2017-12-21 00:01:00,The Motley Fool recommends Cerner.,0.07089276611804962,0.0261527206748724,0.9029545187950134,neutral,0.044740043580532074
61,2017-12-21 00:01:00,The Motley Fool has a disclosure policy .,0.016547100618481636,0.017303917557001114,0.9661489725112915,neutral,-0.0007568169385194778
62,2017-12-21 00:01:00,"The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.",0.010204566642642021,0.01563790813088417,0.9741575717926025,neutral,-0.005433341488242149
